Literature DB >> 30546649

Anomalous left internal mammary artery arising from an aberrant artery of the aorta in a patient with "pseudo bovine" aortic arch anatomy.

Rupak Desai1, Leon Rubinsztain2, Andro Kacharava3.   

Abstract

Many different aortic arch variants have been documented before. Pseudo bovine arch is the most common variant of the aortic arch. Pseudo bovine arch with other factors such as stenosis and calcification impose great difficulties even for experienced cardiologists. Knowledge of anatomical variants is useful information for interventional cardiologist, radiologist, and thoracic surgeons. Left vertebral artery left internal mammary artery (LIMA) alterations have been published a few times before, but here we present a first case to our knowledge with LIMA arising from an aberrant arterial branch of the aorta in a patient with a pseudo bovine aortic arch anatomy. <Learning objective: Variations of the aortic arch are due to alteration in the development of branchial arch arteries during embryonic period. Learn about left internal mammary artery arising from an aberrant arterial branch of the aorta in a patient with a pseudo bovine aortic arch anatomy.>.

Entities:  

Keywords:  Aberrant artery; Anatomic variant; Left internal mammary artery (LIMA); Left vertebral artery (LVA); Pseudo bovine aortic arch

Year:  2016        PMID: 30546649      PMCID: PMC6283006          DOI: 10.1016/j.jccase.2016.03.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  3 in total

1.  Aberrant left internal mammary artery off an aberrant vertebral artery.

Authors:  Jacobo Kirsch; Eric E Williamson
Journal:  Eur Heart J       Date:  2008-02-22       Impact factor: 29.983

2.  Anomalous origin of left internal mammary artery from the lateral junction of the left subclavian artery and aorta.

Authors:  J Chavez; L A Osborn
Journal:  Cathet Cardiovasc Diagn       Date:  1996-02

3.  Anomalous origin of the left internal mammary artery from the aortic arch.

Authors:  Alexander Incani; Joseph C Lee; Karl K Poon; James A Crowhurst; Matthew Pincus; Darren L Walters
Journal:  JACC Cardiovasc Interv       Date:  2012-09       Impact factor: 11.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.